The Cleveland Clinic Lou Ruvo Center for Brain Health will be significantly involved in testing Alzheimer's patients. The National Institutes of Health has approximately $55 million in funding over the next 5 years for a variety of participating centers.
Alzheimer's disease, which causes dramatic problems with memory, thinking and behavior, is the sixth-leading cause of death in the United States. It is the only one, of the top 10, without an identified way to cure, prevent or even slow its progression.
Researchers say that without medical advances, the number of Americans living with the disease is expected to jump from 5.4 million to 16 million in less than 40 years ---- with costs of care projected to rise from $200 billion today to $1.1 trillion in 2050.
The testing will involve the use of Positron Emission Tomography (PET) to measure levels of amyloid accumulation that are generally a precursor to Alzheimer's disease.
The Center will examine whether controlled aerobic exercise can influence cognitive decline, slowing brain atrophy and Alzheimer's symptoms in older adults with mild cognitive impairment, a condition that often leads to Alzheimer's, Reporter Paul Harasim of the Review Journal states.
We will stay tuned on how the testing transpires.